Clinical Trial Update: An Evaluation of SprayShield in Reducing Post-Operative Adhesion Formation Following Major Open Abdominal Surgery [NA]

View source ↗

Summary

A terminated clinical trial evaluating SprayShield to reduce post-operative adhesion formation after major open abdominal surgery, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Adenomatous Polyposis
• Ulcerative Colitis

Drugs mentioned

• SprayShield

Snippet

Sponsor: Integra LifeSciences Corporation | Conditions: Ulcerative Colitis, Familial Polyposis | NA | Status: TERMINATED | Results posted: 2014-01-29